BONE BIOLOGICS CORPORATION: 10-Q filed 2017-11-14

Name: BONE BIOLOGICS CORPORATION: 10-Q filed 2017-11-14
Creator: BONE BIOLOGICS CORPORATION

What BONE BIOLOGICS CORPORATION reported in its quarterly report filed 2017-11-14 (fiscal Q3 2017): 28 published measures, 72 facts as tagged in accession 0001493152-17-013098.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-11-14
Fiscal period: fiscal Q3 2017
Accession: 0001493152-17-013098 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BONE BIOLOGICS CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-09-30	1,940,500	USD
At 2016-12-31	973,085	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-09-30	12,844,975	USD
At 2016-12-31	9,607,141	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-09-30	-10,904,475	USD
At 2016-12-31	-8,634,056	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-09-30	1,621,979	USD
At 2016-12-31	620,375	USD
At 2016-09-30	688,233	USD
At 2015-12-31	1,115,109	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-2,527,419	USD	92
2017-01-01 to 2017-09-30	-4,737,003	USD	273
2007-10-18 to 2017-09-30	52,000,000	USD	3636
2016-07-01 to 2016-09-30	-4,372,271	USD	92
2016-01-01 to 2016-09-30	-16,150,355	USD	274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	-2,398,396	USD	273
2016-01-01 to 2016-09-30	-6,059,987	USD	274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	1,070,000,000	USD	366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	3,400,000	USD	273
2016-01-01 to 2016-09-30	5,633,111	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-09-30	-51,681,060	USD
At 2016-12-31	-46,944,058	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	1,600	USD	273
2016-07-01 to 2016-09-30	1,010	USD	92
2016-01-01 to 2016-09-30	2,745	USD	274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-09-30	170	USD
At 2016-12-31	242	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	1,405,396	USD	273
2016-01-01 to 2016-09-30	2,938,825	USD	274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-1,130,776	USD	92
2017-01-01 to 2017-09-30	-1,315,986	USD	273
2016-07-01 to 2016-09-30	-3,857,415	USD	92
2016-01-01 to 2016-09-30	-14,706,105	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-09-30	1,940,330	USD
At 2016-12-31	972,843	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-09-30	5,642,684	USD
At 2016-12-31	3,324,893	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2017-09-30	225,082	USD
At 2016-12-31	226,516	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	1,130,776	USD	92
2017-01-01 to 2017-09-30	1,315,986	USD	273
2016-07-01 to 2016-09-30	3,857,415	USD	92
2016-01-01 to 2016-09-30	14,706,105	USD	274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	248,377	USD	92
2017-01-01 to 2017-09-30	-1,654,074	USD	273
2016-12-12 to 2016-12-13	3,629,041	USD	2
2016-07-01 to 2016-09-30	2,473,433	USD	92
2016-01-01 to 2016-09-30	9,470,369	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-09-30	39,077,322	shares
At 2016-12-31	38,828,607	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-09-30	40,737,523	USD
At 2016-12-31	38,271,173	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2017-09-30	503	USD
At 2016-12-31	503	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2017-09-30	333	USD
At 2016-12-31	261	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	882,399	USD	92
2017-01-01 to 2017-09-30	2,970,060	USD	273
2016-07-01 to 2016-09-30	1,383,982	USD	92
2016-01-01 to 2016-09-30	5,235,736	USD	274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	72	USD	273
2016-01-01 to 2016-09-30	660	USD	274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-1,396,643	USD	92
2017-01-01 to 2017-09-30	-3,419,417	USD	273
2016-07-01 to 2016-09-30	-513,846	USD	92
2016-01-01 to 2016-09-30	-1,441,505	USD	274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	516,375	USD	273
2016-01-01 to 2016-09-30	555,805	USD	274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	1,600	USD	273
2016-01-01 to 2016-09-30	2,745	USD	274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	700,000	USD	273
2016-01-01 to 2016-09-30	2,500,000	USD	274

Inspect the source

Entity: BONE BIOLOGICS CORPORATION / CIK 0001419554
Captured: 2026-09-20T08:02:52.100Z
SEC response SHA-256: 7c2684db7febb4ea6b03577e138dc91ed20e12534f1d96c178894d4b68a7b815

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001419554.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))